The L'Oréal Group has acquired a majority stake in British skincare brand Medik8. However, founder Elliot Isaacs will remain on the board, and the rest of the board will also remain in place to ensure continuity, L'Oréal announced. Inflexion, a leading European private equity firm specialising in mid-market companies, will also remain a minority shareholder for the time being. The Medik8 brand offers premium skin care products and is best known in Europe and the US for its Crystal Retinal Serum and its trademarked CSA philosophy. This stands for vitamin C and sun protection during the day and vitamin A at night. Further information ...